Cancer
Newly improved method for anti-cancer drug detection： How tiny tumor models could transform drug testing
A team of researchers from Henan University of Science and Technology have introduced a novel method for improving drug testing...
Improved efficacy of pembrolizumab when combined with sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC
“Future development for sEphB4-HSA in HNSCC is likely to focus on patients with HPV-negative disease where there is greatest need...
Cancer risk: Most Australian welders exposed to high levels of dangerous fumes
New Curtin University research has revealed at least 46,000 Australian welders are exposed to high levels of dangerous, potentially cancer-causing...
DDX41 and its unique contribution to myeloid leukemogenesis
“ myeloid neoplasms associated with DDX41 variants likely exhibit a unique pathogenesis that diverges from the conventional understanding of myeloid...
Long-term results from Testicular Cancer treatment are positive, study shows
A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after...
Targeting factors for chemoprevention and cancer interception to tackle mesothelioma
BUFFALO, NY- July 19, 2024 – A new research perspective was published in Oncoscience (Volume 11) on May 23, 2024,...
Fecal immunochemical test screening and risk of colorectal cancer death
About The Study: In this nested case-control study, completing fecal immunochemical test was associated with a lower risk of overall death...
VHIO-led study shows the preclinical promise of systemic targeted therapy in pseudomyxoma peritonei
VHIO-led study shows the preclinical promise of systemic targeted therapy in pseudomyxoma peritonei Credit: VHIO VHIO-led study shows the preclinical...
Hackensack Meridian CDI Lab publishes papers pointing the way toward an exhaled-breath test for lung cancer
July 18, 2024, Nutley, NJ – The foundational science to develop an exhaled-breath test for detection of lung diseases including...
Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment
TAMPA, Fla. — The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!